At a Glance
Companies may now fully deduct eligible domestic research and experimental (R&E) expenses under Internal Revenue Code Section 174 for tax years beginning after December 31, 2024. Companies that previously amortized domestic R&E expenses may also have options to accelerate the recovery of remaining unamortized amounts beginning in 2025.
However, foreign R&E expenses remain subject to 15-year amortization, and state conformity with the federal treatment varies. Businesses should evaluate the interaction between R&E deductions, research and development credits, prior-year filings, and state tax requirements.
Key Takeaways
- Eligible domestic R&E expenses may be fully deducted for tax years beginning after December 31, 2024.
- Taxpayers may have flexibility to accelerate remaining unamortized domestic R&E expenses over one or two years beginning in 2025, or continue amortizing those amounts over the remaining five-year period.
- Foreign R&E expenses must continue to be amortized over 15 years.
- Small businesses can no longer retroactively elect to deduct R&E expenses, as that window closed July 6, 2026, but they may still pursue R&D credit refunds through amended returns.
- Businesses claiming R&D credits must consider the Section 280C election, the impact of reducing R&E deductions, and varying state conformity rules.
Who Is Affected
These changes may affect businesses that incur domestic or foreign R&E expenses, including companies that:
- Previously amortized R&E expenses under Section 174
- Claim, or may be eligible to claim, the R&D credit
- Conduct research activities outside the United States
- Are considering amended tax returns to claim R&D credit refunds
- Operate in multiple states with different conformity, addback, or decoupling rules
Small businesses may be particularly affected when considering amended returns, available R&D credits, and the required treatment of R&E expenses in prior years.
Eligibility and Key Requirements
Eligibility Requirements
Eligible domestic R&E expenses may be fully deducted for tax years beginning after December 31, 2024.
Taxpayers with unamortized domestic R&E expenses may have transition-rule options to accelerate recovery of those amounts or continue amortizing them over the remaining five-year period.
Limits, Thresholds, and Phaseouts
The article does not identify specific dollar limits, income thresholds, or phaseouts for the domestic R&E deduction.
However, taxpayers claiming the R&D credit must determine whether to:
- Claim the gross credit and reduce the related R&E expense deduction
- Elect Section 280C and reduce the credit amount by 21%
Exclusions and Special Rules
Foreign Research
Foreign R&E expenses do not receive the same treatment as domestic R&E expenses. These expenditures must continue to be amortized over 15 years.
Businesses should identify R&E expenditures attributable to foreign research as part of their overall tax planning strategy.
Small Business Retroactive Elections
The period for certain small businesses to retroactively elect to deduct R&E expenses closed on July 6, 2026.
Small businesses may still claim R&D credit refunds through amended returns. However, they should evaluate the available credit, the Section 174 R&E expense addback required for prior years, and the timing of any recovery of remaining unamortized R&E expenses beginning in 2025.
Section 280C Election
Taxpayers may claim the gross R&D credit while offsetting their deduction for R&E expenses, or elect Section 280C and reduce the credit amount by 21%.
Small businesses pursuing amended filings to retroactively deduct R&E expenses are subject to the same rules and must either offset deductions or claim the reduced credit under Section 280C.
Documentation and Reporting
Documentation of eligible R&E expenses remains essential for taxpayers seeking to claim R&D credits and evaluate available deductions.
Businesses should maintain records supporting:
- Domestic and foreign R&E expenses
- The nature and location of research activities
- Previously amortized R&E expenses and remaining unamortized balances
- R&D credit calculations
- Section 280C elections, if applicable
- Amended tax return filings
- State addbacks, conformity adjustments, and other state-specific tax treatment
Effective Dates
- Tax years beginning after December 31, 2024: Eligible domestic R&E expenses may be fully deducted.
- Beginning in 2025: Taxpayers may accelerate recovery of unamortized domestic R&E expenses over a one- or two-year period, or continue amortizing the expenses over the remaining five-year period.
- July 6, 2026: The period for small businesses to retroactively elect to deduct R&E expenses closed.
- Ongoing: Foreign R&E expenses remain subject to 15-year amortization.
IRS procedural guidance is expected and may affect the analysis of available options.
Planning Considerations
Businesses should begin by identifying and separating domestic R&E expenses from foreign R&E expenses, as the tax treatment differs significantly.
Taxpayers with unamortized domestic R&E expenditures should model the potential effect of accelerating deductions over one or two years compared with continuing to amortize the amounts over the remaining five-year period. The most beneficial approach may depend on the company’s taxable income, credit profile, cash flow, and broader tax strategy.
Businesses claiming R&D credits should evaluate whether claiming the gross credit and reducing the related R&E deduction, or making a Section 280C election for a reduced credit, produces the better result.
State tax treatment also requires careful review. While many states conform to the federal restoration of R&E expense deductibility, some have decoupled fully or partially. Other states may allow prospective expensing but not permit a catch-up deduction for previously unamortized R&E expenses. Companies should assess each state’s conformity, addback, and decoupling rules.
Example
A company has remaining unamortized domestic R&E expenses from prior tax years. Beginning in 2025, the company may elect to accelerate the recovery of those remaining amounts over one or two years. Alternatively, it may continue amortizing the expenses over the remaining five-year period.
Before deciding, the company should model the effect of each option on its taxable income, available R&D credits, Section 280C considerations, and state tax obligations.
In contrast, R&E expenses related to foreign research remain subject to 15-year amortization.
Next Steps
- Identify and separate domestic and foreign R&E expenses.
- Review remaining unamortized domestic R&E balances and model available recovery options.
- Evaluate R&D credit opportunities, including the potential effect of a Section 280C election.
- Review state conformity, addback, and decoupling rules in every state where the business has R&E activity or filing obligations.
Don’t let federal Section 174 treatment create unexpected state tax costs. Contact your RKL advisor to review state conformity, addback, and decoupling rules, and to discuss potential tax optimization strategies for R&E expenditures.
Frequently Asked Questions
Can businesses fully deduct R&E expenses?
Eligible domestic R&E expenses may be fully deducted for tax years beginning after December 31, 2024. Foreign R&E expenses remain subject to 15-year amortization.
What happens to domestic R&E expenses that were previously amortized?
Beginning in 2025, taxpayers may generally accelerate recovery of unamortized domestic R&E expenses over one or two years or continue amortizing those amounts over the remaining five-year period.
Can small businesses still retroactively elect to deduct R&E expenses?
No. The window for small businesses to retroactively elect to deduct R&E expenses closed July 6, 2026. However, companies may still pursue R&D credit refunds through amended tax returns.
How does Section 280C affect the R&D credit?
Taxpayers may claim the gross credit while reducing their R&E expense deduction, or they may elect Section 280C and reduce the credit amount by 21%.
Do states follow the federal treatment of R&E expenses?
Not always. Some states have fully adopted the federal treatment, while others have decoupled in whole or in part. Certain states may allow current R&E expensing but not the federal catch-up treatment for prior-year unamortized expenses.